- Remove All
Your shopping cart is currently empty
SD-7300 (SC-81490) functions as an orally active inhibitor targeting MMP-2, MMP-9, and MMP-13, exhibiting potent inhibition with K_i values of 0.03, 0.01, and 0.03 nM, respectively. By inhibiting these metalloproteinases, SD-7300 effectively reduces extracellular matrix degradation by tumor cells, thereby curbing their invasion and metastasis. Additionally, this compound acts as a dose-dependent inhibitor of mouse corneal angiogenesis and prevents interleukin-1-induced degradation of bovine cartilage. SD-7300 is applicable in the study of breast cancer.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,820 | 10-14 weeks | |
| 50 mg | $2,380 | 10-14 weeks | |
| 100 mg | $3,100 | 10-14 weeks |
| Description | SD-7300 (SC-81490) functions as an orally active inhibitor targeting MMP-2, MMP-9, and MMP-13, exhibiting potent inhibition with K_i values of 0.03, 0.01, and 0.03 nM, respectively. By inhibiting these metalloproteinases, SD-7300 effectively reduces extracellular matrix degradation by tumor cells, thereby curbing their invasion and metastasis. Additionally, this compound acts as a dose-dependent inhibitor of mouse corneal angiogenesis and prevents interleukin-1-induced degradation of bovine cartilage. SD-7300 is applicable in the study of breast cancer. |
| Targets&IC50 | MMP-9:0.01 nM (Ki), MMP-2:0.03 nM (Ki), MMP-13:0.03 nM (Ki) |
| Synonyms | SC-81490, PF-02881307 |
| Molecular Weight | 525.54 |
| Formula | C21H30F3N3O7S |
| Cas No. | 748120-89-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.